Inventor · disambiguated record
Konstantin Petrukhin
Also filed as: PETRUKHIN KONSTANTIN
27 granted patents·13 pending applications·292 citations·filing 1999–2025
96Inventor score
Files withPETRUKHIN KONSTANTIN18UNIV COLUMBIA15MERCK & CO INC3BELITE BIO INC2THE TRUSTEES OF COLUMBIA IN THE CITY OF NEW YORK2
Top patents by PatentIndex Score
40 records- 0197US9777010B2Substituted 4-phenylpiperidines, their preparation and usePETRUKHIN KONSTANTIN·Filed 2016·Granted Oct 3, 2017·21 cites·25 claims
- 0297US9434727B2Substituted 4-phenylpiperidines, their preparation and usePETRUKHIN KONSTANTIN·Filed 2015·Granted Sep 6, 2016·29 cites·15 claims
- 0396US11649240B2Substituted 4-phenylpiperidines, their preparation and useUNIV COLUMBIA·Filed 2020·Granted May 16, 2023·4 cites·20 claims
- 0496US10072016B2Substituted 4-phenylpiperidines, their preparation and useUNIV COLUMBIA·Filed 2017·Granted Sep 11, 2018·12 cites·19 claims
- 0596US7179620B2Gene responsible for stargardt-like dominant macular dystrophyMERCK & CO INC·Filed 2006·Granted Feb 20, 2007·43 cites·8 claims
- 0695US10407433B2Substituted 4-phenylpiperidines, their preparation and useUNIV COLUMBIA·Filed 2018·Granted Sep 10, 2019·9 cites·20 claims
- 0795US9944644B2Octahydropyrrolopyrroles their preparation and usePETRUKHIN KONSTANTIN·Filed 2014·Granted Apr 17, 2018·17 cites·18 claims
- 0895US9938291B2N-alkyl-2-phenoxyethanamines, their preparation and usePETRUKHIN KONSTANTIN·Filed 2014·Granted Apr 10, 2018·18 cites·10 claims
- 0994US9926271B2Octahydrocyclopentapyrroles, their preparation and useUNIV COLUMBIA·Filed 2017·Granted Mar 27, 2018·16 cites·28 claims
- 1094US9333202B2Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt diseasePETRUKHIN KONSTANTIN·Filed 2013·Granted May 10, 2016·23 cites·15 claims
- 1193US10913746B2Substituted 4-phenylpiperidines, their preparation and useUNIV COLUMBIA·Filed 2019·Granted Feb 9, 2021·4 cites·20 claims
- 1293US9637450B2Octahydrocyclopentapyrroles, their preparation and usePETRUKHIN KONSTANTIN·Filed 2014·Granted May 2, 2017·22 cites·30 claims
- 1393US8980924B2Non-retinoid RBP4 antagonist for treatment of age-related macular degeneration and stargardt diseasePETRUKHIN KONSTANTIN·Filed 2011·Granted Mar 17, 2015·25 cites·14 claims
- 1492US7091005B2Gene responsible for Stargardt-like dominant macular dystrophyMERCK & CO INC·Filed 2001·Granted Aug 15, 2006·43 cites·6 claims
- 1588US12016853B2Methods of treating RBP4 related diseases with triazolopyridinesBELITE BIO INC·Filed 2021·Granted Jun 25, 2024·1 cites·20 claims
- 1687US12473302B24-phenylpiperidines, their preparation and useUNIV COLUMBIA·Filed 2024·Granted Nov 18, 2025·0 cites·20 claims
- 1784US2024398780A1Methods of treating rbp4 related diseases with triazolopyridinesBELITE BIO INC·Filed 2024·Application pending·0 cites
- 1883US10273243B24-phenylpiperidines, their preparation and useUNIV COLUMBIA·Filed 2014·Granted Apr 30, 2019·2 cites·18 claims
- 1981US2025320218A1Substituted 4-phenylpiperidines, their preparation and useTHE TRUSTEES OF COLUMBIA IN THE CITY OF NEW YORK·Filed 2025·Application pending·0 cites
- 2078US12404277B2Substituted 4-phenylpiperidines, their preparation and useTHE TRUSTEES OF COLUMBIA IN THE CITY OF NEW YORK·Filed 2022·Granted Sep 2, 2025·0 cites·20 claims
- 2177US10787453B2Octahydropyrrolopyrroles their preparation and usePETRUKHIN KONSTANTIN·Filed 2018·Granted Sep 29, 2020·1 cites·20 claims
- 2275US11919913B24-phenylpiperidines, their preparation and useUNIV COLUMBIA·Filed 2021·Granted Mar 5, 2024·0 cites·19 claims
- 2372US11028098B24-phenylpiperidines, their preparation and useUNIV COLUMBIA·Filed 2018·Granted Jun 8, 2021·0 cites·20 claims
- 2469US12440486B2RBP4 antagonists for treatment and prevention of non-alcoholic fatty liver disease and goutUNIV COLUMBIA·Filed 2019·Granted Oct 14, 2025·1 cites·22 claims
- 2564US2024245647A1Isomerohydrolase inhibitor for treatment of atrophic form of age-related macular degeneration and stargardt diseaseUNIV COLUMBIA·Filed 2023·Application pending·0 cites
- 2662US2016030422A1Rbp4 antagonists for the treatment of age-related macular degeneration and stargardt diseasePETRUKHIN KONSTANTIN·Filed 2014·Application pending·0 cites
- 2761US10570148B2N-alkyl-2-phenoxyethanamines, their preparation and useUNIV COLUMBIA·Filed 2018·Granted Feb 25, 2020·0 cites·20 claims
- 2860US10421720B2Octahydrocyclopentapyrroles, their preparation and useUNIV COLUMBIA·Filed 2018·Granted Sep 24, 2019·0 cites·20 claims
- 2956US11000492B2Fluorenone compound for the treatment of goutPETRUKHIN KONSTANTIN·Filed 2016·Granted May 11, 2021·0 cites·20 claims
- 3056US2015057320A1Transthyretin ligands capable of inhibiting retinol-dependent rbp4-ttr interaction for treatment of age-related macular degeneration, stargardt disease, and other retinal disease characterized by excessive lipofuscin accumulationPETRUKHIN KONSTANTIN·Filed 2014·Application pending·0 cites
- 3155US2006287394A1Composition and method for treating macular disordersPETRUKHIN KONSTANTIN·Filed 2004·Application pending·0 cites
- 3255US2017258786A1Rbp4 antagonists for the treatment of age-related macular degeneration and stargardt diseasePETRUKHIN KONSTANTIN·Filed 2017·Application pending·0 cites
- 3352US12168664B2Triazolopyrimidines, their preparation and usePETRUKHIN KONSTANTIN·Filed 2020·Granted Dec 17, 2024·0 cites·20 claims
- 3452US2024150297A1Novel compounds comprising a new class of transthyretin ligands for treatment of common age-related comorbiditiesUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 3551US2016287607A1Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt diseasePETRUKHIN KONSTANTIN·Filed 2016·Application pending·0 cites
- 3650US2023348415A1Bispecific antagonists of retinol-binding protein 4 that stabilize transthyretin tetramers, their preparation, and use in the treatment of common age-related comorbiditiesUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 3745US2006105364A1Best's macular dystrophy genePETRUKHIN KONSTANTIN·Filed 2005·Application pending·0 cites
- 3843US2005262580A1Transgenic mouse with a targeted deletion of Elovl4 genePETRUKHIN KONSTANTIN·Filed 2005·Application pending·0 cites
- 3939US2013189246A1Treatment of ophthalmic conditions with fluorenone derivativesPETRUKHIN KONSTANTIN·Filed 2010·Application pending·0 cites
- 4033US7005290B1Best's macular dystrophy geneMERCK & CO INC·Filed 1999·Granted Feb 28, 2006·1 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Konstantin Petrukhin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →